Rochester, MN, United States of America

Hu Zeng

This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Autoimmune Disease Treatment by Hu Zeng

Introduction

Hu Zeng is an accomplished inventor based in Rochester, MN (US). He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. His innovative approach has the potential to improve the quality of life for many individuals suffering from these conditions.

Latest Patents

Hu Zeng holds a patent for a method of treating a mammal with an autoimmune disease. This method involves administering a SCD1 polypeptide inhibitor to the mammal. The specific compound used in this treatment is characterized by Formula (II). This patent represents a significant advancement in therapeutic options for autoimmune diseases.

Career Highlights

Hu Zeng is affiliated with the Mayo Foundation for Medical Education and Research, a leading institution in medical research and education. His work at this prestigious organization has allowed him to focus on groundbreaking research and innovative treatments.

Collaborations

Hu Zeng collaborates with John A. Copland III, who is also involved in research related to autoimmune diseases. Their partnership enhances the potential for developing effective treatments and advancing medical knowledge in this area.

Conclusion

Hu Zeng's contributions to the treatment of autoimmune diseases through his innovative patent highlight the importance of research and collaboration in the medical field. His work at the Mayo Foundation for Medical Education and Research continues to pave the way for future advancements in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…